홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
GHRS
#7029
GH Research PLC Ordinary Shares
14.850
0
-3.51%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-3.51%
월간 변동
-9.12%
6달 변화
+4.87%
년간 변동율
+4.87%
이전 종가
15.390
0
Open
14.850
0
Bid
Ask
Low
14.850
0
High
14.850
0
양
22
마켓
주식
헬스케어
GHRS
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
52.02 M
52.02 M
52.03 M
52.03 M
208.1 M
Valuation ratios
Enterprise value
936.87 M
337.09 M
199.93 M
263.41 M
2.36 B
Price to earnings ratio
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
Price to book ratio
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.03
0.09
0.16
0.21
—
Return on equity %
0.03
0.09
0.16
0.22
—
Return on invested capital %
—
—
—
—
—
Gross margin %
—
—
—
—
—
Operating margin %
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
101.8
37.07
24.49
17.23
—
Inventory turnover
—
—
—
—
—
Asset turnover
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
Working capital per share
—
—
—
—
—
Book value per share
—
—
—
—
—
뉴스
GH Research 목표 주가, RBC Capital서 40달러로 상향
GH Research stock price target raised to $40 from $33 at RBC Capital
Eli Lilly and Regencell among market cap stock movers on Wednesday
GH Research 목표 주가, Needham에서 19달러에서 29달러로 상향
GH Research stock price target raised to $29 from $19 at Needham
GH Research, FDA 임상 보류 해제로 주가 급등
GH Research stock jumps as Canaccord raises price target on FDA hold lift
GH Research, FDA 임상 보류 해제로 주가 상승
GH Research stock rises as FDA lifts clinical hold on GH001
Psychedelics-Tied GH Skyrockets On FDA Go-Ahead For Depression Drug
Tesla, Chevron among market cap stock movers on Monday
GH Research, TD Cowen "매수" 등급 재확인